U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H11F2NO2
Molecular Weight 215.1966
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIFLUOROMETHYLENEDIOXYAMPHETAMINE

SMILES

CC(N)CC1=CC=C2OC(F)(F)OC2=C1

InChI

InChIKey=BHDXKBALNFHXDV-UHFFFAOYSA-N
InChI=1S/C10H11F2NO2/c1-6(13)4-7-2-3-8-9(5-7)15-10(11,12)14-8/h2-3,5-6H,4,13H2,1H3

HIDE SMILES / InChI

Molecular Formula C10H11F2NO2
Molecular Weight 215.1966
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:41:43 GMT 2023
Edited
by admin
on Sat Dec 16 10:41:43 GMT 2023
Record UNII
8Q2ANL037S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIFLUOROMETHYLENEDIOXYAMPHETAMINE
Common Name English
DIFMDA
Common Name English
1,3-BENZODIOXOLE-5-ETHANAMINE, 2,2-DIFLUORO-.ALPHA.-METHYL-
Systematic Name English
1-(2,2-DIFLUOROBENZO(D)(1,3)DIOXOL-5-YL)PROPAN-2-AMINE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-Difluoromethylenedioxyamphetamine
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
Code System Code Type Description
CAS
910393-51-0
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
PRIMARY
FDA UNII
8Q2ANL037S
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
PRIMARY
WIKIPEDIA
DiFMDA
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
PRIMARY Difluoromethylenedioxyamphetamine (DiFMDA) is a substituted derivative of methylenedioxyamphetamine (MDA), which was developed by Daniel Trachsel and coworkers, along with the corresponding fluorinated derivatives of MDMA, MDEA, BDB and MBDB, with the aim of finding a non-neurotoxic drug able to be used as a less harmful substitute for entactogenic drugs such as MDMA.
PUBCHEM
57467735
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
PRIMARY
EPA CompTox
DTXSID10726729
Created by admin on Sat Dec 16 10:41:43 GMT 2023 , Edited by admin on Sat Dec 16 10:41:43 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE